Skip to main content

Table 1 Participant demographic, behavioral, and clinical characteristics by HIV status

From: HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring

 

HIV-positive

N = 306

n (%)

HIV-negative

N = 500

n (%)

p-value**

Age (years)

< 0.001

 18

22 (7.2)

83 (16.6)

 

 19

40 (13.1)

182 (36.4)

 20

55 (18.0)

97 (19.4)

 21

93 (30.4)

91 (18.2)

 22

96 (31.4)

47 (9.4)

Marital status

< 0.001

 Married/living together

20 (6.5)

1 (0.2)

 

 Single

286 (93.5)

499 (99.8)

Education

< 0.001

 Part of secondary or less

100 (32.7)

0 (0.0)

 

 Secondary

120 (39.2)

0 (0.0)

 Vocational college or more

86 (28.1)

500 (100.0)

Ever had sex

< 0.001

 Yes

265 (86.6)

372 (74.4)

 

 No

41 (13.4)

128 (25.6)

Number of sex partners, past 12 monthsa

0.001

 0

0 (0.0)

1 (0.3)

 

 1

149 (56.2)

230 (61.8)

 2

63 (23.8)

105 (28.2)

 ≥ 3

53 (20.0)

36 (9.7)

Lifetime number of sex partnersa

< 0.001

 0

41 (13.4)

128 (25.6)

 

 1

44 (14.4)

128 (25.6)

 2

52 (17.0)

105 (21.0)

 3–5

126 (41.2)

103 (20.6)

 ≥ 6

43 (14.1)

36 (7.2)

Age of first sex (years)a

0.16

 ≥ 18

207 (78.1)

307 (82.5)

 

 < 18

58 (21.9)

65 (17.5)

Age of first sex partner (years)a

0.002

 ≥ 20

199 (75.1)

235 (63.3)

 

 < 20

66 (24.9)

136 (36.7)

Age of current sex partner (years)a

< 0.001

 ≥ 24

190 (71.7)

123 (33.2)

 

 < 24

75 (28.3)

248 (66.9)

Sexual orientation

0.15

 Heterosexual/straight

300 (98.0)

482 (96.4)

 

 Homosexual/gay or lesbian

2 (0.7)

1 (0.2)

 Bisexual

4 (1.3)

16 (3.2)

 Other

0 (0.0)

1 (0.2)

Condom use in past 3 monthsa

< 0.001

 Always

155 (58.5)

167 (44.9)

 

 Sometimes/never

88 (33.2)

180 (48.4)

 No sex past 3 months

22 (8.3)

25 (6.7)

Tobacco use

0.19

 Daily

1 (0.3)

4 (0.8)

 

 Weekly

4 (1.3)

16 (3.2)

 Never

301 (98.4)

480 (96.0)

Pregnant ever

< 0.001

 Yes

122 (39.9)

42 (8.4)

 

 No

184 (60.1)

458 (91.6)

CD4 count (cells/mm3)

 < 200

9 (3.0)

  

 200–349

45 (14.8)

  

 350–499

64 (21.0)

  

 ≥ 500

187 (61.3)

  

Viral load (copies/mL)

 ≤ 400

283 (94.7)

  

 > 400

16 (5.4)

  

Age of ART initiation (years)

 0–4

12 (3.9)

  

 5–9

47 (15.4)

  

 10–14

28 (9.2)

  

 ≥ 15

219 (71.6)

  

Perinatally infected

 Yes

103 (33.7)

  

 No

203 (66.3)

  
  1. ART antiretroviral therapy
  2. aAmong sexually experienced participants
  3. **Chi-square or Fisher’s exact tests